Internalization of RGD peptide conjugates of near-infrared fluorescent probes in different cell lines occurs via different integrin receptor subtypes

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6097, Issue , 2006, Pages

  Bloch, S ^a   Xu, B ^a   Ye, Y ^a   Liang, K ^a   Achilefu, S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell surface receptors; Integrin; Optical imaging; Peptide; Tumor

Indexed keywords

CELL SURFACE RECEPTORS; INTEGRIN; OPTICAL IMAGING; PEPTIDE;

ANTIBODIES; CELLS; DIMERS; INFRARED IMAGING; TUMORS;

PROTEINS;

EID: 33646175934     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.647811     Document Type: Conference Paper

References (25)

1. Ruoslahti, E. and M. D. Pierschbacher (1987). "New perspectives in cell adhesion: RGD and integrins." Science 238(4826): 491-7.
2. Cheresh, D. A. (1991). "Structure, function and biological properties of integrin alpha v beta 3 on human melanoma cells." Cancer Metastasis Rev 10(1): 3-10.
3. Plow, E. F., T. K. Haas, et al. (2000). "Ligand binding to integrins." Journal of Biological Chemistry 275(29): 21785-21788.
4. Mousa, S. A. (2003). "alpha nu vitronectin receptors in vascular-mediated disorders." Medicinal Research Reviews 23(2): 190-199.
5. Frachet, P., G. Uzan, et al. (1990). "Gpiib and Gpiiia Amino-Acid-Sequences Deduced from Human Megakaryocyte Cdnas." Molecular Biology Reports 14(1): 27-33.
6. Kumar, C. S., I. E. James, et al. (1997). "Cloning and characterization of a novel integrin beta(3) subunit." Journal of Biological Chemistry 272(26): 16390-16397.
7. Wang, X. W., A. M. Ferreira, et al. (2005). "beta 3 integrins facilitate matrix interactions during transendothelial migration of PC3 prostate tumor cells." Prostate 63(1): 65-80.
8. Chattopadhyay, N., A. Mitra, et al. (2001). "Human cervical tumor cell (SiHa) surface alpha(v)beta(3) integrin receptor has associated matrix metalloproteinase (MMP-2) activity." Journal of Cancer Research and Clinical Oncology 127(11): 653-658.
9. Gruber, G., J. Hess, et al. (2005). "Correlation between the tumoral expression of beta 3-integrin and outcome in cervical cancer patients who had undergone radiotherapy." British Journal of Cancer 92(1): 41-46.
10. Pignatelli, M., M. R. Cardillo, et al. (1992). "Integrins and Their Accessory Adhesion Molecules in Mammary Carcinomas - Loss of Polarization in Poorly Differentiated Tumors." Human Pathology 23(10): 1159-1166.
11. Kawahara, E., A. Ooi, et al. (1995). "Integrin Distribution in Gastric-Carcinoma -Association of Beta-3 and Beta-5 Integrins with Tumor Invasiveness." Pathology International 45(7): 493-500.
12. Albelda, S. M., S. A. Mette, et al. (1990). "Integrin Distribution in Malignant-Melanoma - Association of the Beta-3-Subunit with Tumor Progression." Cancer Research 50(20): 6757-6764.
13. Gingras, M. C., E. Roussel, et al. (1995). "Comparison of Cell-Adhesion Molecule Expression between Glioblastoma-Multiforme and Autologous Normal Brain-Tissue." Journal of Neuroimmunology 57(1-2): 143-153.
14. Liekens, S., E. De Clercq, et al. (2001). "Angiogenesis: regulators and clinical applications." Biochemical Pharmacology 61(3): 253-270.
15. Brooks, P. C., A. M. P. Montgomery, et al. (1994). "Integrin Alpha(V)Beta(3) Antagonists Promote Tumor-Regression by Inducing Apoptosis of Angiogenic Blood-Vessels." Cell 79(7): 1157-1164.
16. Brooks, P. C., S. Stromblad, et al. (1995). "Antiintegrin Alpha-V-Beta-3 Blocks Human Breast-Cancer Growth and Angiogenesis in Human Skin." Journal of Clinical Investigation 96(4): 1815-1822.
17. Allman, R., P. Cowburn, et al. (2000). "In vitro and in vivo effects of a cyclic peptide with affinity for the alpha v beta 3 integrin in human melanoma cells." European Journal of Cancer 36(3): 410-422.
18. Haubner, R., H. J. Wester, et al. (2001). "Glycosylated RGD-containing peptides, tracer for tumor targeting and angiogenesis imaging with improved biokinetics." Journal of Nuclear Medicine 42(2): 326-336.
19. van Hagen, P. M., W. A. P. Breeman, et al. (2000). "Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy." International Journal of Cancer 90(4): 186-198.
20. Sivolapenko, G. B., D. Skarlos, et al. (1998). "Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide." European Journal of Nuclear Medicine 25(10): 1383-1389.
21. Haubner, R., H. J. Wester, et al. (1999). "Radiolabeled alpha(v)beta(3) integrin antagonists: A new class of tracers for tumor targeting." Journal of Nuclear Medicine 40(6): 1061-1071.
22. Achilefu, S., R. B. Dorshow, et al. (2000). "Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging." Investigative Radiology 35(8): 479-485.
23. Janssen, M. L., W. J. Oyen, et al. (2002). "Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model." Cancer Research 62(21): 6146-6151.
24. Achilefu, S., S. Bloch, et al. (2005). "Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression." Proceedings of the National Academy of Sciences of the United States of America 102(22): 7976-7981.
25. Atherton, E. and R. C. Sheppard (1989). Solid phase peptide synthesis: a practical appraoch. Oxford, England, Oxford University Press.